Study from Case Western Reserve University and VA Northeast Ohio Healthcare System examines genetic risk profiles across ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize AMD at first.

A new study has revealed that managing eye conditions through enhanced optometric services at local optometrists, rather than ...

Approximately a quarter of Medicare Advantage prescription drug plan members with geographic atrophy also have wet AMD.

Mild traumatic brain injury often leads to visual dysfunctions, even in patients who do not report vision problems.

Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that Health Canada has authorized Vabysmo® (faricimab ...

Further, all patients in the AXPAXLI arm who presented with non-center-involved diabetic macular edema (non-CI-DME ... Khanani, MD, MA, FASRS, Director of Clinic Research at Sierra Eye Associates, ...

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...

To provide your eyes with a little extra relief, we’ve rounded up some of the top editor-tested and shopper-reviewed under-eye patches that quickly brighten and de-puff and are worthy of any ...